Aristeia Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Aristeia Capital’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,306,038	Closed	-$13.4M	–	383
2023 Q1	$13.4M	Buy	1,306,038 +903,138	+224%	+$9.17M	0.31%	81
2022 Q4	$4.05M	Buy	402,900 +152,900	+61%	+$1.52M	0.08%	247
2022 Q3	$2.46M	Buy	+250,000	New	+$2.45M	0.04%	363

Aristeia Capital's ORIA Position: Q2 2023 in Review

Aristeia Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 1,306,038 shares — an estimated $13.4M sold.

Aristeia Capital first reported a position in ORIA in Q3 2022 and held it in 3 quarters. The position peaked at $13.4M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Aristeia Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Aristeia Capital sold 1,306,038 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $13.4M.
Aristeia Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 3 quarters.
Aristeia Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $13.4M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Aristeia Capital's 13F filing for Q2 2023, filed 14 Aug 2023.